Related Experiment Video
Updated: Jul 15, 2025

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Axenic Long-Term Cultivation of Pneumocystis jirovecii
Diana Riebold1, Marie Mahnkopf1, Kristina Wicht2
1Research Centre of Medical Technology and Biotechnology (FZMB), 99947 Bad Langensalza, Germany.
Abstract:
Pneumocystis jirovecii, a fungus causing severe Pneumocystis pneumonia (PCP) in humans, has long been described as non-culturable. Only isolated short-term experiments with P. jirovecii and a small number of experiments involving animal-derived Pneumocystis species have been published to date. However, P. jirovecii culture conditions may differ significantly from those of animal-derived Pneumocystis, as there are major genotypic and phenotypic differences between them. Establishing a well-performing P. jirovecii cultivation is crucial to understanding PCP and its pathophysiological processes. The aim of this study, therefore, was to develop an axenic culture for Pneumocystis jirovecii. To identify promising approaches for cultivation, a literature survey encompassing animal-derived Pneumocystis cultures was carried out. The variables identified, such as incubation time, pH value, vitamins, amino acids, and other components, were trialed and adjusted to find the optimum conditions for P. jirovecii culture. This allowed us to develop a medium that produced a 42.6-fold increase in P. jirovecii qPCR copy numbers after a 48-day culture. Growth was confirmed microscopically by the increasing number and size of actively growing Pneumocystis clusters in the final medium, DMEM-O3. P. jirovecii doubling time was 8.9 days (range 6.9 to 13.6 days). In conclusion, we successfully cultivated P. jirovecii under optimized cell-free conditions in a 70-day long-term culture for the first time. However, further optimization of the culture conditions for this slow grower is indispensable.
Insights
Researchers successfully cultivated Pneumocystis jirovecii (PJP) in a lab setting for the first time. This breakthrough in PJP culture is crucial for understanding Pneumocystis pneumonia (PCP) and developing new treatments.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Microbiology
Background:
- Pneumocystis jirovecii (PJP) causes severe Pneumocystis pneumonia (PCP) in humans.
- PJP has historically been considered non-culturable, hindering research into PCP.
- Existing studies on Pneumocystis species primarily involve animal models, with significant genotypic and phenotypic differences from PJP.
Purpose of the Study:
- To develop the first successful axenic (cell-free) culture conditions for Pneumocystis jirovecii.
- To establish a reliable method for cultivating PJP to facilitate research into PCP pathogenesis and treatment.
Main Methods:
- Conducted a literature survey of animal-derived Pneumocystis culture methods.
- Systematically trialed and optimized variables including incubation time, pH, vitamins, and amino acids.
- Utilized quantitative PCR (qPCR) and microscopy to assess PJP growth and viability in the developed medium (DMEM-O3).
Main Results:
- Achieved a 42.6-fold increase in PJP qPCR copy numbers after 48 days of culture.
- Confirmed microscopic evidence of actively growing PJP clusters in the DMEM-O3 medium.
- Determined the PJP doubling time to be approximately 8.9 days under the optimized conditions.
Conclusions:
- Successfully established the first long-term axenic culture of Pneumocystis jirovecii.
- The developed culture conditions represent a significant advancement for studying PJP and PCP.
- Further optimization is necessary for this slow-growing fungus to fully elucidate its biology and clinical implications.
More Related Videos
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment